expert reaction to an analysis of global obesity trends
A study in Nature looks at global obesity trends in developed and developing nations. Dr Marie Spreckley, Research Programme Manager, University … read more
A study in Nature looks at global obesity trends in developed and developing nations. Dr Marie Spreckley, Research Programme Manager, University … read more
There’s a current perception that we’re facing a ‘global obesity epidemic’ of rising rates of obesity in young people and … read more
A randomised controlled trial published in Nature Medicine looks at pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight … read more
A randomised controlled trial published in Nature Medicine looks at the use of Orforflipron for maintenance of body weight reduction. … read more
A study published in Nature Medicine looks at an association between GLP-1 use and breast cancer survival and recurrence. Dr Mangesh … read more
A randomised controlled trial published in The Lancet looks at the use of semaglutide in patients with alcohol use disorder and comorbid … read more
A study published in Nature Medicine looks at a new tool (OBSCORE) to prioritise individuals at high risk of obesity-related complications for … read more
Obesity is a major global health challenge, with 60-70 per cent of adults in the western countries living with overweight … read more
A randomised controlled trial published in JAMA Psychiatry looks at semaglutide use and motivation in depression. Prof Ciara McCabe, Professor of … read more
A systematic review published in PLOS One looks at an association between ultra-processed food (UPF) consumption and overweight or obesity in … read more
A study published in Nature looks at genetic predictors of GLP-1 medication weight loss and side effects. Dr Marie Spreckley, Research … read more
Experts comment on draft NICE guidance that recommends semaglutide to reduce the risk of heart attacks and strokes. Prof … read more
A meta-analysis published in eClinicalMedicine looks at weight regain trajectories after stopping GLP-1 receptor agonist medication. Dr Adam Collins, Associate … read more
A review published in the Cochrane Database of Systematic Reviews looks at intermittent fasting for adults with obesity. Dr Baptiste … read more
A systematic review and meta-analysis published in the BMJ looks at weight regain after stopping obesity drugs. Prof Jason … read more
What happens to body weight and measures of cardiometabolic health after people stop taking obesity drugs? A new systematic review … read more
Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
A modelling study published in the Lancet Regional Health – Europe looks at the impact of nutrition labelling policies on obesity … read more
A study published in the Lancet looks at semaglutide and cardiovascular health regardless of weight loss. Dr Sonya Babu-Narayan, Clinical Director, … read more
An unpublished conference abstract presented at the European Association for the Study of Diabetes (EASD) looks at a new RNA-based weight … read more